संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

energique, inc - hypericum perforatum (unii: xk4iux8mnb) (hypericum perforatum - unii:xk4iux8mnb) - hypericum perforatum 200 [hp_c] in 1 ml - may temporarily relieve nerve issues, especially after injury.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. may temporarily relieve nerve issues, especially after injury.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - hypericum perforatum (unii: xk4iux8mnb) (hypericum perforatum - unii:xk4iux8mnb) - hypericum perforatum 3 [hp_x] - uses: temporary relief - sharp pains, wounds* * claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. condition listed above or as directed by the physician

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

hyland's inc. - hypericum perforatum (unii: xk4iux8mnb) (hypericum perforatum - unii:xk4iux8mnb) - hypericum perforatum 6 [hp_x] - pain or minor injuries to extremities pain or minor injuries to extremities

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

homeolab usa inc - hypericum perforatum (unii: xk4iux8mnb) (hypericum perforatum - unii:xk4iux8mnb) - hypericum perforatum 3 [hp_x] - shooting pain for self-limiting condition listed above or as directed by a health professional.

ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bell laboratories, inc. - zinc phosphide; malathion - ready-to-use bait - zinc phosphide ungrouped active 20.0 g/kg; malathion organophosphorus other 0.11 g /kg - vertebrate poison - canola - see label | grain crop | legume crop | nut crop | pasture - refer to label for use | safflower - refer to label - rodent, rat or mouse | black rat/mouse | brown rat/mouse | mouse | rat | rodent | roof rat

ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - zinc phosphide - bait - zinc phosphide ungrouped active 25.0 g/kg - vertebrate poison - agricultural or horticultural situation | canola | grain crop | legume crop | nuts | pasture | safflowers | high intensity usage - mouse - mus spp.

कनाडा - अंग्रेज़ी - Health Canada

avir pharma inc. - sincalide - powder for solution - 5mcg - sincalide 5mcg - gallbladder function

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

energique, inc. - hypericum perforatum (unii: xk4iux8mnb) (hypericum perforatum - unii:xk4iux8mnb), comfrey root (unii: m9vvz08ekq) (comfrey root - unii:m9vvz08ekq), arnica montana (unii: o80ty208zw) (arnica montana - unii:o80ty208zw) - hypericum perforatum 12 [hp_x] in 1 ml - may temporarily relieve soreness after overexertion, pain and soreness after procedures, and pain and soreness after injury and trauma.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. may temporarily relieve soreness after overexertion, pain and soreness after procedures, and pain and soreness after injury and trauma.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate (unii: 89ds0h96tb) (zinc cation - unii:13s1s8sf37) - zinc sulfate injection is indicated in adult and pediatric patients as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. zinc sulfate injection is contraindicated in patients with known hypersensitivity to zinc [see warnings and precautions (5.6)] risk summary administration of the approved recommended dose of zinc sulfate injection in parenteral nutrition is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with intravenous zinc sulfate.  the estimated background risk of major birth defects and miscarriage for the indicated populations is unknown.  all pregnancies have a background risk of birth defect, loss, or other adverse outcomes.  in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. clinical considerations disease-associated maternal and/or embryo-fetal risk deficiency of trace elements, including zinc, is associated with adverse pregnancy and fetal outcomes. pregnant women have an increased metabolic demand for trace elements, including zinc.  parenteral nutrition with zinc should be considered if a pregnant woman’s nutritional requirements cannot be fulfilled by oral or enteral intake. risk summary zinc is present in human milk. administration of the approved recommended dose of zinc sulfate injection in parenteral nutrition is not expected to cause harm to a breastfed infant. there is no information on the effects of zinc sulfate on milk production. the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for zinc sulfate injection and any potential adverse effects on the breastfed infant from zinc sulfate injection or from the underlying maternal condition. zinc sulfate injection is approved for use in the pediatric population, including neonates, as a source of zinc for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. safety and dosing recommendations in pediatric patients are based on published literature describing controlled studies of zinc-containing products in pediatric patients [see dosage and administration (2.2)] . because of immature renal function, preterm infants receiving prolonged parenteral nutrition treatment with zinc sulfate injection may be at higher risk of aluminum toxicity [see warnings and precautions (5.3)] . reported clinical experience with intravenous zinc sulfate has not identified a difference in zinc requirements between elderly and younger patients.  in general, dose selection should be individualized based on the patient’s clinical condition, nutritional requirements, and additional nutritional intake provided orally or enterally to the patient.

सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

medquest marketing pte ltd - general hospital - the icu medical mednet™ medication management suite (mms) is intended to facilitate networked communication between mms compatible computer systems and mms compatible infusion pumps. the mms provides trained healthcare professionals with the capability to send, receive, report, and store information from interfaced external systems, and to configure and edit infusion programming parameters. the mms is intended to provide a way to automate the programming of infusion parameters, thereby decreasing the amount of manual steps necessary to enter infusion data. all data entry and validation of infusion parameters is performed by a trained healthcare professional according to physician’s orders.